Table 2.
LRLs and URLs with SDs, obtained from the meta-analysis study for mGFR (in mL/min/1.73 m2)
| Age at mid-point | LRL | SD | FAS-LRL | URL | SD | FAS-URL | FASalt-URL |
|---|---|---|---|---|---|---|---|
| (years) | |||||||
| 25 | 78.1 | 5.5 | 80.7 | 136.0 | 7.6 | 160.1 | 133.9 |
| 35 | 76.8 | 4.6 | 80.7 | 133.8 | 7.1 | 160.1 | 133.9 |
| 45 | 70.1 | 6.0 | 76.0 | 128.5 | 7.0 | 150.8 | 126.1 |
| 55 | 62.1 | 10.5 | 67.3 | 118.6 | 9.7 | 133.6 | 111.7 |
| 65 | 55.3 | 7.4 | 59.7 | 114.0 | 10.0 | 118.4 | 99.0 |
| 75 | 48.6 | 5.3 | 52.9 | 102.8 | 11.3 | 105.0 | 87.8 |
‘Age’ is defined as the mid-point of the age interval. LRL and URL are the means of the lower and upper limits calculated from the meta-analysis data [6]. FAS is the prediction for SCr/Q = 1.33 (LRL) and SCr/Q = 0.67 (URL) at the corresponding age. FASalt-URL is defined as the upper limit symmetrical with the lower limit.